Evidence map›Paper›PMID 42609106›Full record

ArticleJournal of microbiology and biotechnology2026

Evaluation of Microbiome Therapeutic Candidates for Carbapenem-Resistant

Ali Atashi, Hoonhee Seo, Hanieh Tajdozian, Faezeh Sarafraz, Md Sarower Hossen Shuvo, Sukyung Kim, Ho-Yeon Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ali AtashiDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam 31151, Republic of Korea.
Hoonhee SeoK-Microbiome Institute, 813-26 Yisunsin-daero, 22, Asan, Chungnam 31462, Republic of Korea.
Hanieh TajdozianDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam 31151, Republic of Korea.
Faezeh SarafrazDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam 31151, Republic of Korea.
Md Sarower Hossen ShuvoDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam 31151, Republic of Korea.
Sukyung KimK-Microbiome Institute, 813-26 Yisunsin-daero, 22, Asan, Chungnam 31462, Republic of Korea.
Ho-Yeon SongDepartment of Microbiology and Immunology, School of Medicine, Soonchunhyang University, Cheonan, Chungnam 31151, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbapenem-resistant

Indexed as

Anti-Bacterial AgentsBacterial CapsulesCarbapenem-Resistant EnterobacteriaceaeMicrobiotaAnimalsCarbapenemsEnterobacteriaceae InfectionsHumansKlebsiella pneumoniaeLactobacillusMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsCapsular polysaccharide (CPS) suppressionCarbapenem-resistant Enterobacteriaceae (CRE)Cell-free supernatantsKlebsiella pneumoniaeMicrobiome therapeuticsProbiotics

Identifiers

PMID42609106
PMCPMC13486752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.